Loading clinical trials...
Loading clinical trials...
Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma
Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
Stanford University School of Medicine
Stanford, California, United States
Start Date
March 1, 2008
Primary Completion Date
March 1, 2013
Completion Date
September 1, 2013
Last Updated
June 29, 2016
135
ACTUAL participants
Lead Sponsor
Stanford University
NCT06345508
NCT07024641
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07447050